Cigna Group
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 2, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Oct 1, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Aug 4, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Aug 3, 2026 | Raymond James | downgrade | Strong Buy → Outperform | — | 54% |
| Jul 31, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 31, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 31, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jul 9, 2026 | Bernstein | maintain | Outperform → Outperform | — | 52% |
| Jun 8, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 26, 2026 | Barclays | downgrade | Overweight → Equal-Weight | — | 53% |
| May 22, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 20, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 20, 2026 | Deutsche Bank | downgrade | Buy → Hold | — | 57% |
| May 5, 2026 | Bernstein | maintain | Outperform → Outperform | — | 52% |
| May 4, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 1, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 1, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| May 1, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 1, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 20, 2026 | Jefferies | maintain | Buy → Buy | — | 52% |
| Mar 12, 2026 | Bernstein | upgrade | Market Perform → Outperform | — | 52% |
| Mar 3, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Feb 17, 2026 | Truist Securities | reiterate | Buy → Buy | $350 | 54% |
| Feb 9, 2026 | TD Cowen | maintain | Buy → Buy | $338 | 54% |
| Feb 6, 2026 | RBC Capital | maintain | Outperform → Outperform | $333 | 55% |
| Feb 6, 2026 | Barclays | maintain | Overweight → Overweight | $303 | 53% |
| Feb 6, 2026 | Guggenheim | maintain | Buy → Buy | $334 | 52% |
| Feb 2, 2026 | Guggenheim | reiterate | Buy → Buy | $318 | 52% |
| Jan 5, 2026 | Truist Securities | maintain | Buy → Buy | $320 | 54% |
| Jan 5, 2026 | Barclays | maintain | Overweight → Overweight | $305 | 53% |
| Nov 12, 2025 | Bernstein | maintain | Market Perform → Market Perform | $294 | 52% |
| Nov 5, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $300 | 54% |
| Nov 4, 2025 | TD Cowen | maintain | Buy → Buy | $333 | 54% |
| Nov 4, 2025 | Goldman Sachs | maintain | Buy → Buy | $330 | 54% |
| Nov 4, 2025 | JP Morgan | maintain | Overweight → Overweight | $375 | 54% |
| Nov 3, 2025 | Barclays | maintain | Overweight → Overweight | $300 | 53% |
| Oct 14, 2025 | Goldman Sachs | initiate | — → Buy | $370 | 54% |
| Sep 4, 2025 | Barclays | maintain | Overweight → Overweight | $383 | 53% |
| Aug 26, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $365 | 50% |
| Aug 14, 2025 | Baird | maintain | Outperform → Outperform | $374 | 55% |
| Aug 14, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $340 | 54% |
| Aug 4, 2025 | Guggenheim | maintain | Buy → Buy | $350 | 52% |
| Aug 1, 2025 | Barclays | maintain | Overweight → Overweight | $354 | 53% |
| Jun 26, 2025 | RBC Capital | reiterate | Outperform → Outperform | $371 | 55% |
| Jun 3, 2025 | RBC Capital | reiterate | Outperform → Outperform | $371 | 55% |
| Jun 2, 2025 | Barclays | maintain | Overweight → Overweight | $385 | 53% |
| May 23, 2025 | Guggenheim | reiterate | Buy → Buy | $388 | 52% |
| May 12, 2025 | Truist Securities | maintain | Buy → Buy | $405 | 54% |
| May 6, 2025 | Guggenheim | maintain | Buy → Buy | $388 | 52% |
| May 5, 2025 | Piper Sandler | maintain | Overweight → Overweight | $374 | 54% |
No cross-platform signals in the last 90 days